Search This Blog

Sunday, March 24, 2019

Magenta Therapeutics downgraded to Neutral from Buy at Goldman Sachs

Goldman Sachs downgraded Magenta Therapeutics to Neutral on valuation.
https://thefly.com/landingPageNews.php?id=2883433
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)